Muka Metal S.A. has been acquired by Stryker Corporation
The private shareholders and owners of Muka Metal, A.S. have sold the company to Stryker Corporation. Financial details have not been disclosed.
Since launching its first hospital bed in 2002, Muka Metal has established itself as a leading manufacturer and marketer of hospital beds, stretchers and related patient room furniture and accessories. In 2014, Muka Metal finished the construction of a state-of-the-art facility located in a free trade zone within Kayseri, Turkey.
Headquartered in Kalamazoo, Michigan,USA, Stryker Corporation is one of the world's leading medical technology companies and offers a diverse array of innovative products and services in orthopedics, medical and surgical, and neurotechnology and spine, which help improve patient and hospital outcomes. This transaction will expand Stryker’s presence in Turkey as well as in Latin America, while also providing a product portfolio that complements and enhances Stryker's current portfolio.
"The acquisition of Muka Metal aligns with our strategy to expand our global presence through existing channels with an established and trusted brand," said Timothy J. Scannell, Stryker Group President, MedSurg and Neurotechnology. "This acquisition will bolster Stryker Medical's bed and stretcher offerings, and is a compelling opportunity to drive growth in Turkey and other regions around the world."
Oaklins' team in Turkey acted as the exclusive financial advisor to the seller in this transaction.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more